BOT 4.94% 38.5¢ botanix pharmaceuticals ltd

Ann: FDA Approves Sofdra, page-422

  1. 636 Posts.
    lightbulb Created with Sketch. 405
    So you're saying, BOT will have annual revenue of $3Billion? Keep in mind CSL has a revenue of $9 Billion across ALL their brands. Then, what the hell does Sales per Share indicate without EPS. COGS is generally used to define the manufacture of goods, not gross cost to customer.
    These "costings" make absolutely no sense whatsover. Most useful piece of information on there is that works out SOI but my 12 year old can do that within 5 seconds on a calculator.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
38.5¢
Change
-0.020(4.94%)
Mkt cap ! $698.4M
Open High Low Value Volume
40.0¢ 40.0¢ 38.0¢ $3.442M 8.886M

Buyers (Bids)

No. Vol. Price($)
2 26467 38.5¢
 

Sellers (Offers)

Price($) Vol. No.
39.0¢ 135324 3
View Market Depth
Last trade - 16.10pm 18/09/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.